Naš glavni prispevek je, da terapija z trajnim sproščanjem združuje prednosti kemoterapije in imunoterapije, prvič pa sta se z intervencijo združila in uporabljala za intratumorsko terapijo. It integrates local and global treatment, and increases the concentration and time of drug action through sustained release of drugs within the tumor, which not only plays a local anticancer effect of chemotherapy drugs, but also takes into account the role of systemic immunotherapy, thus making up for the shortcomings of other therapies, providing new ideas and approaches for cancer treatment, especially for middle and advanced tumors, especially for reducing tumor recurrence and inhibiting tumor The transfer has very pomembna vrednost; Prednost UMPIC ima prednost uporabe tumorja kot vira antigena in avtolognega cepiva, ki je v skladu tudi z razvojnim trendom personalizirane medicine. In se uporablja za kliniko, Hapten v kombinaciji s kemoterapijo za zdravila za trajno sproščanje primarnega fokusa raka trebušne slinavke, hkrati pa povzroča distalni učinek, katerega bistvo je induciranje imunskega odziva, T-celic, povezanih s CD4, CD8, DC, T in NK, in P16, P16, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53, P53. Koc, Survivin, p62, HCC1 and other oncogenes, this is the first time to find that T and B are involved in the immune response, and the clinical functions of the distal effect and this therapy was selected for "Clinical Operation Guidelines for Interventional Treatment of Advanced Pancreatic Cancer" (Trial) (7th edition) jointly formulated by the Chinese Anti-Cancer Association, the National Clinical Medical Research Center for Radiology and Therapy, and the National Interventional Medicine Innovation Alliance je bil objavljen na

Časopis za klinično radiologijo, letnik 43, številka 19, 2024, 1636-1648.